YOU SHOULD BE TALKING ABOUT AND PROMOTING EARLY TREATMENT. Early treatment with
Monoclonal Antibodies, Ivermectin, Hydroxychloroquine, Prednisone, Singulair, Azithromycin, nasal
viricidal therapy, etc have been shown to vastly reduce hospitalizations and improve outcomes for
Covid patients both vaccinated and unvaccinated. This is how you END the pandemic.
Please see below the studies conducted on mask effectiveness and that I would like to use to support my
argument:
e Face Masks (cloth and/or surgical)
o Have no impact on controlling the transmission of COVID-19 virus and are largely ineffective.
o Current evidence implies that face masks are harmful
o The following studies were conducted:https://www.acpjournals.org/doi/10.7326/M20-6817
Effectiveness of Adding a Mask recommendation to Other Public Health Measures to
Prevent SARS CoV-2 Infection in Danish Mask Wearers
RESULTS: The difference observed was not statistically significant
o Another study conducted: https://www.cato.org/sites/cato.org/files/202 1-11 /working-paper-
64.pdf
CONCLUSION: We reviewed the mechanistic, observational, and clinical
evidence relevant to the use of cloth face masks in community settings to limit
the spread of respiratory infections, and in particular the novel SARS-CoV-2
coronavirus. In each area, we found existing evidence inadequate to
demonstrate clear benefit (or harm). It is an ethical imperative to refrain from
portraying the evidence is stronger than it actually is. Some models supporting
community face masks suggest large beneficial effects,319,320 but these models
are based on assumptions that face masks reduce SARS-CoV-2 transmission by
40-—50%321,322,323—assumptions that are not adequately supported by
existing data. More generally, given the low quality of evidence, the absence of
statistically significant benefit indicated by most randomized controlled trials, and
the possible harm suggested by a few studies, scientists and public health
officials must take care not to apply a double standard to available studies—
emphasizing projections of lives saved when evidence suggests benefit, while
focusing on study limitations rather than outcomes when the evidence suggests
harm or the absence of benefit.
o Dr. Brosseau and Dr. Sietsema University of Illinois at Chicago:
https://www.cidrap.umn.edu/news-perspective/2020/04/commentary-masks-al…-
based-sound-data
We do, however, have data from laboratory studies that indicate cloth masks or
face coverings offer very low filter collection efficiency for the smalier inhalable
particles we believe are largely responsible for transmission, particularly from
pre- or asymptomatic individuals who are not coughing or sneezing.
We know of workplaces in which employees are told they cannot wear
respirators for the hazardous environments they work in, but instead need to
wear a cloth mask or face covering. These are dangerous and inappropriate
applications that greatly exceed the initial purpose of a cloth mask. We are
concerned that many people do not understand the very limited degree of
protection a cloth mask or face covering likely offers as source control for people
located nearby.
we continue to conclude that cloth masks and face coverings are likely to
have limited impact on lowering COVID-19 transmission, because they
2
